소아의 난치성 신증후군의 한약 치료에 대한 최신 임상연구 동향
Review of Clinical Research for Herbal Medicine Treatment on Refractory Nephrotic Syndrome in Children
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study is to analyze clinical studies on effectiveness of herbal medicine in refractory nephrotic syndrome (RNS). Methods: We searched the randomized controlled trials (RCTs) with herbal medicine treatment on RNS from the Pubmed, CNKI, OASIS, NDSL, J-stage, and CiNii. The demographic data, duration of illness, intervention, treatment period, outcome, adverse events, and composition of herbal medicine were analyzed for this study. Results: 11 RCT studies were selected and analyzed. The children in the control group were given western medicine therapy, and the treatment group was given herbal medicine along with the same western medicine of the control group. The most commonly used herbal medicines were the prescriptions to treat ‘Kidney Deficiency with Blood Stasis (腎虛兼瘀血)’ which composed of ‘Promoting blood circulation (化瘀)’, ‘Diuresis-inducing (利水)’, or ‘Heating Yang (溫陽)’ medicine based on ‘Replenishing Kidney or Spleen (補腎, 補脾)’ medicine. In the treatment group, proteinuria and serum lipid was significantly decreased, serum albumin was significantly increased, and total effective rate was significantly higher than the control group. Hypercoagulation and relapse rate was also significantly reduced. Adverse events were significantly lower in the treatment group. Conclusions: Herbal medicine treatment on pediatric RNS can be suggested as a new treatment for children who have less response to the conventional therapy. It can also supplement the limitations of the western medicine by reducing adverse events from the steroids and immuno-suppressive agents, and lower the relapse rate as well.
Abstract
Objectives: The purpose of this study is to analyze clinical studies on effectiveness of herbal medicine in refractory nephrotic syndrome (RNS). Methods: We searched the randomized controlled trials (RCTs) with herbal medicine treatment on RNS from the Pubmed, CNKI, OASIS, NDSL, J-stage, and CiNii. The demographic data, duration of illness, intervention, treatment period, outcome, adverse events, and composition of herbal medicine were analyzed for this study. Results: 11 RCT studies were selected and analyzed. The children in the control group were given western medicine therapy, and the treatment group was given herbal medicine along with the same western medicine of the control group. The most commonly used herbal medicines were the prescriptions to treat ‘Kidney Deficiency with Blood Stasis (腎虛兼瘀血)’ which composed of ‘Promoting blood circulation (化瘀)’, ‘Diuresis-inducing (利水)’, or ‘Heating Yang (溫陽)’ medicine based on ‘Replenishing Kidney or Spleen (補腎, 補脾)’ medicine. In the treatment group, proteinuria and serum lipid was significantly decreased, serum albumin was significantly increased, and total effective rate was significantly higher than the control group. Hypercoagulation and relapse rate was also significantly reduced. Adverse events were significantly lower in the treatment group. Conclusions: Herbal medicine treatment on pediatric RNS can be suggested as a new treatment for children who have less response to the conventional therapy. It can also supplement the limitations of the western medicine by reducing adverse events from the steroids and immuno-suppressive agents, and lower the relapse rate as well.
참고문헌 (50)
- A. A. Eddy, "Nephrotic syndrome in childhood", The Lancet, 362(9384), pp.629~639 (2003)
- International study of kidney disease in Children, "Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis", Kidney Int, 13(1), pp.159~165 (1978)
- Ko KW, "Childhood renal diseases in Korea: A clinicopathological study of 657cases", Pediatr Nephrol, 1(1), pp.664~669 (1987)
- R. K. Chandra, "Refractory nephrotic syndrome", Nihon Rinsho, 62(10), pp.1794~1799 (2004)
- K. L. Gibson, "Emerging Agents for the Management of Nephrotic Syndrome:Progress to Date", Pediatric Drugs, 18(1), pp.25~29 (2016)
- Koskimies O, "Long-term outcome of primary nephrotic syndrome", Arch Dis Child, 57(2), pp.544~548 (1982)
- Spitzer A, "A report of international study of kidney disease in children:prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome", Lancet, 2(1), pp.423~427 (1974)
- Waldo FB, "Methylprednisolone treatment of patients with steroid resistant nephrotic syndrome", Pediatr Nephrol, 6(2), pp.503~505 (1992)
- Cattran DC, "Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations", Kidney Int, 72(12), pp.1429~1447 (2007)
- Garin EH, "Cyclosporine therapy for steroid resistant nephrotic syndrome. A controlled study", Am J Dis Child, 142(3), pp.985~988 (1988)
- Lieberman KV, "A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children", J Am Soc Nephrol, 7(1), pp.56~63 (1996)
- Ponticelli C, "A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome", Kidney Int, 43(4), pp.1377~1384 (1993)
- El-Husseini A, "Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience", Nephrol Dial Transplant, 20(11), pp.2433~2438 (2005)
- V. D. B. Ja, "Long term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy", J Am Soc Nephrol, 25(1), pp.150~158 (2014)
- Kim KB, "Hanbangsoacheongsonyeonuihak (ha)", pp.184~186 (2015), Eui Sung Dang Publishing Co
- Wang XQ, "Traditional chinese medicine for refractory nephrotic syndrome: strategies and promising treatments", Evid Based Complement Alternat Med, pp.1~11 (2018)
- Xu G, "Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis", Nephron Clin Pract, 111(1), pp.223~228 (2009)
- Kim DH, "A clinical case report of nephrotic syndrome", J Daejeon Univ. Korean Med, 14(2), pp.1~4 (2005)
- Ahn YM, "The Immuno-regulatory effects of Onbi-tang and Dangguijakyak-san in minimal change nephrotic syndrome", J Korean med, 21(1), pp.20~28 (2000)
- Lee MG, "The Immuno-regulatory effects of Chungsimyeunjaeum and Daebunchungeum in minimal change nephrotic syndrome", J Kyunghee Univ, 23(1), pp.51~70 (2000)
- Wei L, "Clinical study of primary refractory nephrotic syndrome in children treated by Wenyang-lishui-huayu therapy", Chin J Inf Trad Chin Med, 36(5), pp.66~70 (2019)
- Xia SQ, "Thirty-nine cases of refractory nephrotic syndrome in children treated with Bao shenxiao-zhuo decoction", Henan Trad Chin Med, 38(10), pp.1552~1554 (2018)
- Wang XH, "Observe the curative effect of refractory nephrotic syndrome of children in treatment with chinese medicine", Chinese Health Standard Management, 6(8), pp.74~75 (2015)
- Lu SK, "Treatment of Cānlíngbáishùsàn jiājiăn(蔘苓白朮散 加減) on refractory nephropathy in children", Henan Trad Chin Med, 34(9), pp.1765~1766 (2014)
- Li DL, "Study of effects of TCM combined treatment on refractory nephritic syndrome in children", Chin J Med Guide, 15(9), pp.1465~1466 (2013)
- Zheng J, "Effect of Shenkangling Decoction on Neuropetide Y in Frequent Relase Nehritic Syndrome in Children", J Trad Chin Med, 53(9), pp.755~757 (2012)
- Zheng J, "Intervention effect of Shenkangling on lipoprotein a in children with frequent relapse nephrotic syndrome", JFUTCM, 20(4), pp.4~6 (2010)
- Zheng J, "Clinical research on Shenkangling decoction in treating 30 children with frequent relapse nephrotic syndrome", JFUTCM, 19(2), pp.1~3 (2010)
- Ai S, "The clinical research on NF-кB, TXB2, 6-keto-PGF1α in children with FRNS by treatment of decoction Shenkangling by tonifying the kindey and promoting blood circulation", Master, pp.2008
- Wei JH, "The clinical research on children with FRNS by treatment of decoction Shenkangling and cortisol, TXA2, PGI2", Master, pp.2006
- Wu LQ, "53 Clinical observation on children’s refractory nephrotic syndrome treated with Yiqi-Zishen-Huoxue-Fang 75Cases", JSCTCM, 3(3), pp.20~22 (2002)
- Chinese medical association of pediatrics nephrology, "Child hormone sensitivity, relapse", nephropathy-dependent syndrome evidence-based guidelines for diagnosis and treatment (兒童激素敏感反復, Chin J Pediatr, pp.2017, 10(55)[DOI]
- Borel JF, "Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome", Clin Nephrol, 35(1), pp.23~30 (1991)
- Heo J, "Donguibogam", pp.898~ (2012), Beob In Publishing Co
- Wang XQ, "Immune glomerular diseases difficulties and Chinese medicine treatment strategies", Chin J Integr Trad West Nephr, 11(2), pp.169~171 (2010)
- Wang XQ, "Traditional chinese medicine for refractory nephrotic syndrome: strategies and promising treatments", Evid Based Complement Altern Med, (1), pp.1~11 (2018)
- Chinese Medicine Association, "Guidelines for the diagnosis and treatment of common diseases in chinese medicine pediatrics", pp.40~77 (2012), China Traditional Chinese Medicine Press
- State Administration of Traditional Chinese Medicine, "Diagnostic and therapeutic criteria for TCM syndromes", pp.278~299 (2012), China Medical Science and Technology Press
- Norma A, "Course and resolution of the coagulopathy in nephrotic children", Kidney Int, 31(1), pp.772~ (1987)
- Wu QH, "Clinical study of Sijunzi decoction and Liuwei dihuang decoction for chronic nephritis with Qi and Yin deficiency pattern", Progress in Modern Biomedicine, 16(36), pp.7113~7116 (2016)
- Nie JT, "Efficacy of fangjihuangqi decoction in treatment of patients with primary nephrotic syndrome in edema period and its influence on 24hr urinary protein, serum albumin and lipid", Clinical J Chin Med Pract, 21(1), pp.48~51 (2017)
- Han L, "Clinical therapeutic research of idiopathic membranous nephropathy by YiqiHuoxue Huashi Project and analysis of correlative influencing factors", Chin J Integr Trad West Nephr, 11(1), pp.879~883 (2010)
- Leehey DJ, "Remission of membranous nephropathy after therapy with astragalus membranaceus", Am J Kidney Dis, 55(4), pp.772~ (2010)
- Ahmed MS, "Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus", Am J Kidney Dis, 50(6), pp.1028~1032 (2007)
- Shi JF, "Therapeutic effect of Astragalus in patients with chronic glomerulonephritis", Acta Univ Medicinalis Secondae Shanghai, 22(3), pp.245~247 (2002)
- Wang YJ, "Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial", Journal of Ethnopharmacology, 139(3), pp.757~764 (2012)
- Chen XR, "Clinical observation on curative effect of primary nephrotic syndrome treated with JiaweiFangji HuangqiTang and its effects on serum IL-10 and TNF-α", Trad Chin Med Technology, 23(4), pp.393~395 (2016)
- Cao GH, "Clinical Study on Fangji Huangqi Decoction Treatment of Children with Nephrotic Syndrome", Acta Chin Med, 32(10), pp.2009~2012 (2017)
- Hao M, "Professor Yang Shuo-ping plus-minus against oneself Huang Qi Tang intreatment of nephrotic syndrome (Feng Shui-combination) clinical observation of 46 cases", Clinical J Chin Med, 30(6), pp.68~70 (2014)
- Herbology Editorial Committee of Korean Medicine schools, "Boncho-hak", pp.418~419 (2004), Young-Lim Press
